Epigenetic signature helps predict risk of metastatic thyroid cancer progression

Epigenetic signature helps predict risk of metastatic thyroid cancer progression

Researchers from the Endocrine Tumors group at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with five university hospitals, have conducted the first comprehensive study of DNA methylation patterns in metastatic differentiated thyroid cancer (DTC).

IGTP Study Uncovers Epigenetic Signature Predicting Outcomes in Metastatic

In a groundbreaking study published in the journal Thyroid, researchers from the Endocrine Tumours group at the Germans Trias i Pujol Research Institute (IGTP), in close collaboration with five university hospitals, have mapped the intricate dynamics of DNA methylation in metastatic differentiated thyroid cancer (DTC). This pioneering research reveals a distinct epigenetic signature consisting of 156 CpG sites within primary tumors, a discovery …